Int Ophthalmol Clin. 2014;54(1):103-114. Topiramate is typically started at 25 mg daily and can be titrated up to 100 mg twice daily. It is frequently given in addition to acetazolamide in the ...

For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional ...

Int Ophthalmol Clin. 2014;54(1):27-41. Much of the data supporting weight loss as treatment for IIH comes from retrospective studies or class III evidence. There has been a long-standing need for ...

If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this disorder can develop without noticeable symptoms, making it hard to catch.

A new study led by investigators from Mass General Brigham shows that a brain waste- "clean-up" system is influenced by intracranial pressure. The system, called the glymphatic system, was ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Idiopathic intracranial hypertension is prevalent among ...

Idiopathic intracranial hypertension (IIH) is characterised by elevated intracranial pressure without identifiable intracranial pathology and most commonly affects obese women of reproductive age.

Please provide your email address to receive an email when new articles are posted on . Patients with idiopathic intracranial hypertension can be managed medically. For surgical management, consider ...

GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema. (HealthDay News) — For patients with idiopathic intracranial ...